March 2020 Archives

Homepage
About Us
Services
News Feed
Contact
English
- English
- 中文

Homepage
About Us
Services
News Feed
Contact
English
- English
- 中文

Russian Federation Pharma – March 2020 update

June 8, 2020

No comments

News

Russian Federation Pharma – March 2020 update

KYBORA is an experienced global advisory firm that maintains close direct connections with the top 20 market leaders through regular updates and networking

Recent blog post.

The Latest Trends on Biotech Companies with Negative Enterprise Values: Insights and Implications

Posted: 4 weeks ago
KYBORA Advises Lupin on the Divestiture of U.S. Commercial Women’s Health Specialty Business to Evofem

Posted: 1 month ago
KYBORA’s Charitable Work

Posted: 2 months ago
Join KYBORA at BIO 2024

Posted: 3 months ago
Foundation Rwanda Update

Posted: 5 months ago

Tags.

#biopharma Licensing Announcement Bausch Health biopharma biotechnology China Conference Corporate globalhealthcare healthtech Kybora Team LIcensing March 2020 mergersandacquisitions News Priority List Stada license

Tell us about your business and corporate development needs.

Contact Us

Kybora is a global advisory firm whose mission is to help life sciences companies achieve enduring success by offering optimal M&A, licensing, fundraising and strategic consulting services in all key markets around the world.

About Us.

About Kybora
Meet our team
Success Story
Our Global Presence

Our Services.

M&A
Licensing
Fundraising
Strategic Advisory

Latest News Feed.

The Latest Trends on Biotech Companies with Negative Enterprise Values: Insights and Implications

Posted: 4 weeks ago
KYBORA Advises Lupin on the Divestiture of U.S. Commercial Women’s Health Specialty Business to Evofem

Posted: 1 month ago

Terms of service | Privacy policy

Recent blog post.

Tags.

TYPE & ENTER: